Infection control wins stimulus funds

Publication
Article
Oncology NEWS InternationalOncology NEWS International Vol 18 No 11
Volume 18
Issue 11

An investigator at Fred Hutchinson Cancer Center in Seattle has earned a $1.74 million grant under the American Recovery & Reinvestment Act of 2009.

An investigator at Fred Hutchinson Cancer Center in Seattle has earned a $1.74 million grant under the American Recovery & Reinvestment Act of 2009.

Recipient Colleen Delaney, MD, is an assistant member in the Fred Hutchinson center’s clinical research division. Her goal is to find to ways to reduce the risk of infection, and early death, in patients who receive cord blood transplants.

In her ongoing research, Dr. Delaney developed a novel culture methodology, which demonstrated that neutrophils can be generated from a single unit of cord blood. In addition, these cells are capable of rapid recovery when infused in the clinical setting. These findings could change the way transplant is done.

Newsletter

Stay up to date on recent advances in the multidisciplinary approach to cancer.

Recent Videos
2 experts in this video
2 experts in this video
Extravasation with beta emitters may elicit more drastic adverse effects due to their higher radiation dose.
Increasing the use of patient-reported outcomes may ensure that practitioners can fully ascertain the impact of treatment for rare lymphomas.
Photographic and written documentation can help providers recognize inflammatory breast cancer symptoms across diverse populations.
The use of guideline-concordant care in breast cancer appears to be more common in White populations than Black populations.
2 experts are featured in this series.
Related Content